Innovation Pharmaceuticals Inc (IPIX)

[BonelessCat]

Did you look at Aveo’s balance sheet? -586,969,000 accumulated deficit, with a net operating loss of over 65 million for 2017. No income from collaborations, partnerships or licenses. No income from approved drugs. They raised more than 586 million yet the share structure remains at just north of 100 million shares. How many reverse splits to raise 586 million and qualify for NASDAQ listing? Do you think they will spend another $65 million in 2018 to get approval in the US?

IPIX is actively seeking a license or partner that will raise as much capital over time as AVEO’s accumulated deficit. Maybe more if they license the B platform. Big difference between the two companies and business plans.